Skip to main content
Top
Published in: Modern Rheumatology 2/2013

01-03-2013 | Original Article

Association between transforming growth factor-α polymorphism and ankylosing spondylitis: a meta-analysis update

Authors: Chencheng Wang, Hong Su, Weiwei Chang, Zhiwei Xu, Qin Han, Xiaowei Shan

Published in: Modern Rheumatology | Issue 2/2013

Login to get access

Abstract

Objectives

The reported results of the relationship between genetic polymorphisms of tumor necrosis factor (TNF)-α −238, −308 locus and ankylosing spondylitis (AS) susceptibility are not always consistent. This article aims to perform a meta-analysis to collect all the relevant studies to date to further clarify the relationship between those genetic polymorphisms and AS.

Methods

A computer search was carried out up to September 2011 for literature pertaining to AS and TNF-α polymorphisms.

Results

Twenty-two articles were included, with 2,506 cases of AS and 3,023 normal controls. We searched for genotypes A allele vs. G allele, AA vs. GG + GA, and GA + AA vs. GG in a fixed/random-effects model. The effect summary odds ratios (ORs) and 95 % confidence intervals (CIs) were obtained, which shows there was no association between genetic polymorphisms and AS. As the heterogeneity was observed, in a subgroup analysis by ethnicity, the degree of risk of two genes with AS susceptibility was similar in populations of European and Asian origin. For the human leukocyte antigen (HLA)-B27+ population, results were not statistically significant.

Conclusion

ORs of various comparisons indicate that there is no association between TNF-α −238, −308 polymorphisms and AS susceptibility in the overall population and in the subgroup of Asian and non-Asian descent.
Appendix
Available only for authorised users
Literature
1.
go back to reference Thomas GP, Brown MA. Genetics and genomics of ankylosing spondylitis. Immunol Rev. 2010;233:162–80.PubMedCrossRef Thomas GP, Brown MA. Genetics and genomics of ankylosing spondylitis. Immunol Rev. 2010;233:162–80.PubMedCrossRef
2.
go back to reference Thomas GP, Brown MA. Genomics of ankylosing spondylitis. Discov Med. 2010;10:263–71.PubMed Thomas GP, Brown MA. Genomics of ankylosing spondylitis. Discov Med. 2010;10:263–71.PubMed
3.
go back to reference Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthr Rheum. 1995;38:499–505.CrossRef Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, et al. Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthr Rheum. 1995;38:499–505.CrossRef
4.
go back to reference Sousa E, Caetano-Lopes J, Pinto P, Imentel F, Teles J, Canhão H. Ankylosing spondylitis susceptibility and severity—contribution of TNF gene promoter polymorphisms at positions −238 and −308. Ann N Y Acad Sci. 2009;1173:581–8.PubMedCrossRef Sousa E, Caetano-Lopes J, Pinto P, Imentel F, Teles J, Canhão H. Ankylosing spondylitis susceptibility and severity—contribution of TNF gene promoter polymorphisms at positions −238 and −308. Ann N Y Acad Sci. 2009;1173:581–8.PubMedCrossRef
5.
go back to reference Kaijzel EL, Brinkman BM, van Krugten MV, Smith L, Huizinga TW, Verjans GM, et al. Polymorphism within the tumor necrosis factor a (TNF) promoter region in patients with ankylosing spondylitis. Hum Immunol. 1999;60:140–4.PubMedCrossRef Kaijzel EL, Brinkman BM, van Krugten MV, Smith L, Huizinga TW, Verjans GM, et al. Polymorphism within the tumor necrosis factor a (TNF) promoter region in patients with ankylosing spondylitis. Hum Immunol. 1999;60:140–4.PubMedCrossRef
6.
go back to reference Brown MA. Progress in spondylarthritis. Progress in studies of the genetics of ankylosing spondylitis. J Arthr Res Ther. 2009;11(5):254 (Epub 2009 Oct 29, Review). Brown MA. Progress in spondylarthritis. Progress in studies of the genetics of ankylosing spondylitis. J Arthr Res Ther. 2009;11(5):254 (Epub 2009 Oct 29, Review).
7.
go back to reference McGarry F, Walker R, Sturrock R, Field M. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol. 1999;26:1110–6.PubMed McGarry F, Walker R, Sturrock R, Field M. The -308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27. J Rheumatol. 1999;26:1110–6.PubMed
8.
go back to reference González S, Torre-Alonso JC, Martínez-Borra J, Fernández Sánchez JA, López-Vazquez A, Rodríguez Pérez A, et al. TNF −238 A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients. J Rheumatol. 2001;28:1288–93.PubMed González S, Torre-Alonso JC, Martínez-Borra J, Fernández Sánchez JA, López-Vazquez A, Rodríguez Pérez A, et al. TNF −238 A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients. J Rheumatol. 2001;28:1288–93.PubMed
9.
go back to reference Milicic A, Lindheimer F, Laval S, Rudwaleit M, Ackerman H, Wordsworth P, et al. Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis. Genes Immun. 2000;1:418–22.PubMedCrossRef Milicic A, Lindheimer F, Laval S, Rudwaleit M, Ackerman H, Wordsworth P, et al. Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis. Genes Immun. 2000;1:418–22.PubMedCrossRef
10.
go back to reference Rudwaleit M, Siegert S, Yin Z. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF −308 gene polymorphism. Ann Rheum Dis. 2001;60:36–42.PubMedCrossRef Rudwaleit M, Siegert S, Yin Z. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF −308 gene polymorphism. Ann Rheum Dis. 2001;60:36–42.PubMedCrossRef
11.
go back to reference Lin JA, Ye DF, et al. Polymerase chain reaction analysis for the tumor necrosis factor alpha −308 gene polymorphism in relation to ankylosing spondylitis. Chin J Rheumatol. 2003;7:420–2. Lin JA, Ye DF, et al. Polymerase chain reaction analysis for the tumor necrosis factor alpha −308 gene polymorphism in relation to ankylosing spondylitis. Chin J Rheumatol. 2003;7:420–2.
12.
go back to reference Liu QH, Teng Y, Wu QM, Shen LX, Wang H, Chen Y, et al. Relationship between polymorphism in promoter regions of tumor necrosis factor gene and ankylosing spondylitis. Chin J Rheumatol. 2002;6:402–5. Liu QH, Teng Y, Wu QM, Shen LX, Wang H, Chen Y, et al. Relationship between polymorphism in promoter regions of tumor necrosis factor gene and ankylosing spondylitis. Chin J Rheumatol. 2002;6:402–5.
13.
go back to reference Cai Q, Liu CG, Wang YJ, Zhan Z, Cheng T. Gene polymorphism of the promoter region 308 site of the tumor necrosis factor-α in ankylosing spondylitis. Acad J PLA Postgrad Med Sch. 2007;28:279–81. Cai Q, Liu CG, Wang YJ, Zhan Z, Cheng T. Gene polymorphism of the promoter region 308 site of the tumor necrosis factor-α in ankylosing spondylitis. Acad J PLA Postgrad Med Sch. 2007;28:279–81.
14.
go back to reference Lu MC, Yang KL, Tung CH, et al. Higher LPS-stimulated TNF-a mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with −308 G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes. Rheumatol Int. 2008;29:189–95.PubMedCrossRef Lu MC, Yang KL, Tung CH, et al. Higher LPS-stimulated TNF-a mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with −308 G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes. Rheumatol Int. 2008;29:189–95.PubMedCrossRef
15.
go back to reference Shiau MY, Lo MK, Chang CP, Yang TP, Ho KT, Chang YH. Association of tumour necrosis factor alpha promoter polymorphisms with ankylosing spondylitis in Taiwan. Ann Rheum Dis. 2007;66:562–3.PubMedCrossRef Shiau MY, Lo MK, Chang CP, Yang TP, Ho KT, Chang YH. Association of tumour necrosis factor alpha promoter polymorphisms with ankylosing spondylitis in Taiwan. Ann Rheum Dis. 2007;66:562–3.PubMedCrossRef
16.
go back to reference Chung WT, Choe JY, Jang WC, et al. Polymorphisms of tumor necrosis factor-a promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population. Rheumatol Int. 2011;31:1167–75.PubMedCrossRef Chung WT, Choe JY, Jang WC, et al. Polymorphisms of tumor necrosis factor-a promoter region for susceptibility to HLA-B27-positive ankylosing spondylitis in Korean population. Rheumatol Int. 2011;31:1167–75.PubMedCrossRef
17.
go back to reference Nicknam MH, Mahmoudi M, Amirzargar AA, Jamshidi AR, Rezaei N, Nikbin B. HLA-B27 subtypes and tumor necrosis factor alpha promoter region polymorphism in Iranian patients with ankylosing spondylitis. Eur Cytokine Netw. 2009;20:17–20.PubMed Nicknam MH, Mahmoudi M, Amirzargar AA, Jamshidi AR, Rezaei N, Nikbin B. HLA-B27 subtypes and tumor necrosis factor alpha promoter region polymorphism in Iranian patients with ankylosing spondylitis. Eur Cytokine Netw. 2009;20:17–20.PubMed
18.
go back to reference Vargas-Alarcon G, Casasola-Vargas J, Rodriguez-Perez JM, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol. 2006;67:826–32.PubMedCrossRef Vargas-Alarcon G, Casasola-Vargas J, Rodriguez-Perez JM, et al. Tumor necrosis factor-alpha promoter polymorphisms in Mexican patients with spondyloarthritis. Hum Immunol. 2006;67:826–32.PubMedCrossRef
19.
go back to reference Yang B, Chen RW, Duan SW, et al. Influence of polymorphism in −238 and −308 sites of TNF-α promoter regions on susceptibility and phenotype of ankylosing spondylitis. Acad J Sec Mil Med Univ. 2004;25:125–8. Yang B, Chen RW, Duan SW, et al. Influence of polymorphism in −238 and −308 sites of TNF-α promoter regions on susceptibility and phenotype of ankylosing spondylitis. Acad J Sec Mil Med Univ. 2004;25:125–8.
20.
go back to reference Martinez-Borra J, Gonzalez S, Lopez-Vazquez A, et al. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Hum Immunol. 2000;61:131–9.PubMedCrossRef Martinez-Borra J, Gonzalez S, Lopez-Vazquez A, et al. HLA-B27 alone rather than B27-related class I haplotypes contributes to ankylosing spondylitis susceptibility. Hum Immunol. 2000;61:131–9.PubMedCrossRef
21.
go back to reference Fraile A, Nieto A, Vinasco J, et al. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens. 1998;51:386–90.PubMedCrossRef Fraile A, Nieto A, Vinasco J, et al. Tumor necrosis factor gene polymorphisms in ankylosing spondylitis. Tissue Antigens. 1998;51:386–90.PubMedCrossRef
22.
go back to reference Hohler T, Schaper T, Schneider PM, Meyer ZBK, MarkerHermann E. Association of different tumor necrosis factor lpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum. 1998;41:1489–92.PubMedCrossRef Hohler T, Schaper T, Schneider PM, Meyer ZBK, MarkerHermann E. Association of different tumor necrosis factor lpha promoter allele frequencies with ankylosing spondylitis in HLA-B27 positive individuals. Arthritis Rheum. 1998;41:1489–92.PubMedCrossRef
23.
go back to reference Verjans GM, Brinkman BM, Van Doornik CE, et al. Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position −308 in relation to ankylosing spondylitis. Clin Exp Immunol. 1994;97:45–7.PubMedCrossRef Verjans GM, Brinkman BM, Van Doornik CE, et al. Polymorphism of tumour necrosis factor-alpha (TNF-alpha) at position −308 in relation to ankylosing spondylitis. Clin Exp Immunol. 1994;97:45–7.PubMedCrossRef
24.
go back to reference Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA. The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol. 2009;27:645–64.PubMed Chatzikyriakidou A, Georgiou I, Voulgari PV, Drosos AA. The role of tumor necrosis factor (TNF)-alpha and TNF receptor polymorphisms in susceptibility to ankylosing spondylitis. Clin Exp Rheumatol. 2009;27:645–64.PubMed
25.
go back to reference Wang M, Du SJ, et al. Study on the gene polymorphism of TNF-α −238 in ankylosing spondylitis (AS) patients in human population. Chin J Immunol. 2010;26:136–40. Wang M, Du SJ, et al. Study on the gene polymorphism of TNF-α −238 in ankylosing spondylitis (AS) patients in human population. Chin J Immunol. 2010;26:136–40.
26.
go back to reference Mei YJ. Relationship between gene polymorphism in TNF-α promoter regions and susceptibility to ankylosing spondylitis. Chin J Allergy Cunical Immunol. 2009;3:173–7. Mei YJ. Relationship between gene polymorphism in TNF-α promoter regions and susceptibility to ankylosing spondylitis. Chin J Allergy Cunical Immunol. 2009;3:173–7.
27.
go back to reference Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analyses. Stat Med. 2002;21:1539–58.PubMedCrossRef Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analyses. Stat Med. 2002;21:1539–58.PubMedCrossRef
28.
go back to reference Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press; 2000. p. 306. Petitti DB. Meta-analysis, decision analysis, and cost-effectiveness analysis. New York: Oxford University Press; 2000. p. 306.
29.
go back to reference Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335–71.PubMedCrossRef Yusuf S, Peto R, Lewis J, et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335–71.PubMedCrossRef
30.
go back to reference Egger M, Davey SG, Schneider M, et al. Bias in meta analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMedCrossRef Egger M, Davey SG, Schneider M, et al. Bias in meta analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.PubMedCrossRef
31.
go back to reference Li Bing, Wang Pei. Hui Li.The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis. Clin Rheumatol. 2010;29:983–90.PubMedCrossRef Li Bing, Wang Pei. Hui Li.The association between TNF-alpha promoter polymorphisms and ankylosing spondylitis: a meta-analysis. Clin Rheumatol. 2010;29:983–90.PubMedCrossRef
32.
go back to reference Lee YH, Song GG. Lack of association of TNF-αpromoter polymorphisms with ankylosing spondylitis: a meta-analysis. Rheumatology. 2009;48:1359–62.PubMedCrossRef Lee YH, Song GG. Lack of association of TNF-αpromoter polymorphisms with ankylosing spondylitis: a meta-analysis. Rheumatology. 2009;48:1359–62.PubMedCrossRef
33.
go back to reference Seitz M, Wirthmuller U, Moller B, Villiger PM. The −308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNF alpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford). 2007;46:93–6.CrossRef Seitz M, Wirthmuller U, Moller B, Villiger PM. The −308 tumour necrosis factor-alpha gene polymorphism predicts therapeutic response to TNF alpha-blockers in rheumatoid arthritis and spondyloarthritis patients. Rheumatology (Oxford). 2007;46:93–6.CrossRef
34.
go back to reference Poddubnyy DA, Märker-Hermann E, Kaluza-Schilling W, Zeidler H, Braun J, Listing J, et al. Relation of HLA-B27, tumor necrosis factor-promoter gene polymorphisms, and t cell cytokine production in ankylosing spondylitis—a comprehensive genotype-phenotype analysis from an observational cohort. J Rheumatol. 2011;38:11. doi:10.3899/jrheum.110130. Poddubnyy DA, Märker-Hermann E, Kaluza-Schilling W, Zeidler H, Braun J, Listing J, et al. Relation of HLA-B27, tumor necrosis factor-promoter gene polymorphisms, and t cell cytokine production in ankylosing spondylitis—a comprehensive genotype-phenotype analysis from an observational cohort. J Rheumatol. 2011;38:11. doi:10.​3899/​jrheum.​110130.
35.
go back to reference Aguillón JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? Immunobiology. 2006;211:75–84.PubMedCrossRef Aguillón JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M. Could single-nucleotide polymorphisms (SNPs) affecting the tumour necrosis factor promoter be considered as part of rheumatoid arthritis evolution? Immunobiology. 2006;211:75–84.PubMedCrossRef
36.
go back to reference Bennett PH, Burch TA. New York symposium on population studies in the rheumatic diseases: new diagnostic criteria. Bull Rheum Dis. 1967;17:453. Bennett PH, Burch TA. New York symposium on population studies in the rheumatic diseases: new diagnostic criteria. Bull Rheum Dis. 1967;17:453.
37.
go back to reference Van der Linden S, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthr Rheum. 1984;27:361–8.CrossRef Van der Linden S, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthr Rheum. 1984;27:361–8.CrossRef
38.
go back to reference Yang QR, Zhang YC, Su HS, et al. The association between ankylosing spondylitis with polymorphism in −308 site of TNF-α promoter region: the meta analysis. China J Rheumatol. 2007;11:365–9. Yang QR, Zhang YC, Su HS, et al. The association between ankylosing spondylitis with polymorphism in −308 site of TNF-α promoter region: the meta analysis. China J Rheumatol. 2007;11:365–9.
Metadata
Title
Association between transforming growth factor-α polymorphism and ankylosing spondylitis: a meta-analysis update
Authors
Chencheng Wang
Hong Su
Weiwei Chang
Zhiwei Xu
Qin Han
Xiaowei Shan
Publication date
01-03-2013
Publisher
Springer Japan
Published in
Modern Rheumatology / Issue 2/2013
Print ISSN: 1439-7595
Electronic ISSN: 1439-7609
DOI
https://doi.org/10.1007/s10165-012-0659-0

Other articles of this Issue 2/2013

Modern Rheumatology 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.